Stage IIA Breast Cancer (DBCOND0029213)

Identifiers

Synonyms
Breast Cancer Stage IIA

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04088435
Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast CancerNo drug interventionsNot AvailableNot Availableterminated
NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNo drug interventionstreatment2recruiting
NCT03723863
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing ChemotherapyNo drug interventionssupportive_careNot Availableterminated
NCT04553770
Trastuzumab Deruxtecan Alone or in Combination with Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancertreatment2recruiting
NCT02370264
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast CancerNo drug interventionssupportive_careNot Availableterminated
NCT00450879
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgerytreatment1terminated
NCT02168179
KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01730833
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancertreatment2active_not_recruiting
NCT01238133
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancertreatment1terminated
NCT02235051
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT02454777
High-Intensity Interval Training for Stage I-III Breast Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT02370277
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01106898
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgerytreatment2completed
NCT01570998
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT02699983
eHealth Weight Loss Program in African American Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02314156
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomyprevention2completed
NCT03091842
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancertreatment1terminated
NCT01606241
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancertreatment1completed
NCT01897441
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancertreatmentNot Availableactive_not_recruiting
NCT03139435
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03050463
Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01928186
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerdiagnosticNot Availablecompleted
NCT03198286
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01319539
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast CancerNo drug interventionstreatment2terminated
NCT02702830
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03102866
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03345420
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast CancerNo drug interventionstreatment2active_not_recruiting
NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumorstreatment1completed
NCT01750073
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancertreatment2active_not_recruiting
NCT02445391
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapytreatment3active_not_recruiting
NCT03039140
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02780401
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remissionprevention1active_not_recruiting
NCT02957968
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Catreatment2active_not_recruiting
NCT03284346
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availableterminated
NCT02927912
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With ReconstructionNo drug interventionstreatment2recruiting
NCT03233555
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02566408
Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical ActivityNo drug interventionssupportive_careNot Availablecompleted
NCT01776008
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancertreatment2terminated
NCT01753908
Broccoli Sprout Extract in Treating Patients With Breast CancerNo drug interventionsbasic_science0completed
NCT00066690
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancertreatment3active_not_recruiting
NCT02415387
Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancerbasic_science0completed
NCT02526498
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryNo drug interventionstreatment2completed
NCT01409811
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidtreatmentNot Availableterminated
NCT03188393
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryNo drug interventionsother2suspended
NCT01293032
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancertreatmentNot Availablecompleted
NCT03061175
Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03414970
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerNo drug interventionssupportive_care3active_not_recruiting
NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancertreatment2active_not_recruiting
NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)No drug interventionshealth_services_researchNot Availablecompleted
NCT02662335
Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03025139
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)No drug interventionssupportive_careNot Availableunknown_status
NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgerytreatment2recruiting
NCT01525966
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancertreatment2active_not_recruiting
NCT02400060
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT02677389
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinNo drug interventionssupportive_careNot Availablecompleted
NCT02488967
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancertreatment3active_not_recruiting
NCT02432950
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01849250
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivorsprevention2completed
NCT02414646
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancertreatment2active_not_recruiting
NCT03156309
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remissionprevention1recruiting